SCHEMBL8300867

SCHEMBL8300867

O=C1Nc2cccnc2N(Cc2ccccc2)c2ncccc21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.53
CYP1A2 P05177 2/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
APP P05067 2/20 0.46
MAPT P10636 2/20 0.46
SNCA P37840 2/20 0.46
BRD4 O60885 1/20 0.45
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
ALDH1A1 P00352 2/20 0.44
ALOX15 P16050 1/20 0.44
MAPK10 P53779 1/20 0.44
HSD17B10 Q99714 1/20 0.44
USP2 O75604 1/20 0.43
LMNA P02545 1/20 0.43
CHRM2 P08172 1/20 0.43
CHRM4 P08173 1/20 0.43
CHRM5 P08912 1/20 0.43
CYP2D6 P10635 1/20 0.43
CHRM1 P11229 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2700771 0.90 RAB9A (0.60) RAB9ACYP1A2BRD4ALDH1A1USP2
SCHEMBL8299610 0.85 MAPT (0.52) RAB9AAPPMAPTSNCABRD4
SCHEMBL8300334 0.82 RAB9A (0.50) RAB9ACYP1A2SMN1; SMN2ALDH1A1ALOX15
SCHEMBL8301869 0.80 CHRM2 (0.48) RAB9ACYP1A2SMN1; SMN2ALDH1A1USP2
SCHEMBL9705877 0.76 CYP1A2 (0.53) RAB9ACYP1A2SMN1; SMN2ALDH1A1ALOX15
SCHEMBL9369774 0.76 RAB9A (0.59) RAB9ACYP1A2ALDH1A1USP2LMNA
SCHEMBL8790717 0.76 RAB9A (0.53) RAB9ACYP1A2SMN1; SMN2ALDH1A1USP2
SCHEMBL2473625 0.76 CASP3 (0.61) CYP1A2APPMAPTSNCABRD4
SCHEMBL6963218 0.75 CYP3A4 (0.46) RAB9ACYP1A2SMN1; SMN2BRD4CHRM2
SCHEMBL8300613 0.75 BRD4 (0.60) APPMAPTSNCABRD4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0429987-B1 5,11-Dihydro-6H-dipyrido[3,2-b:2',3'-e] [1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMA (US) 1999-03-17 EP disclosed
US-5620974-A ENZYME INHIBITOR, TREATS ACQUIRED IMMUNE DEFICIENCY SYNDROME(AIDS) BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1997-04-15 US disclosed
US-5366972-A 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1994-11-22 US disclosed
EP-0393529-B1 5,11-dihydro-6H-dipyrido [3,2-b:2',3'-e][1,4]diazepin-6-ones and their use in the prevention or treatment of AIDS Boehringer Ingelheim Pharmaceuticals Inc. (US) 1993-06-30 EP disclosed
EP-0429987-A2 5,11-Dihydro-6H-dipyrido[3,2-b:2',3'-e] [1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 1991-06-05 EP disclosed
EP-0393529-A1 5,11-dihydro-6H-dipyrido [3,2-b:2',3'-e][1,4]diazepin-6-ones and their use in the prevention or treatment of AIDS Boehringer Ingelheim Pharmaceuticals Inc. (US) 1990-10-24 EP disclosed